医薬品有効成分市場：タイプ、合成、メーカー、治療用途別-2023～2030年の世界予測

医薬品有効成分の世界市場は、2023年にCAGR 6.67%で2,270億1,000万米ドルと予測され、2030年には驚異的な3,572億7,000万米ドルに達すると予測され、大きく成長すると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界の医薬品有効成分市場を評価するために不可欠です。事業戦略と製品満足度の主要指標を調査することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客ベース、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.医薬品有効成分の世界市場規模および予測は？

2.予測期間中、世界の医薬品有効成分市場を形成するCOVID-19の阻害要因と影響は？

3.医薬品有効成分の世界市場において予測期間中に投資すべき製品/セグメント/用途/分野は？

4.医薬品有効成分の世界市場における競争戦略は？

5.医薬品有効成分の世界市場における技術動向と規制の枠組みは？

6.医薬品有効成分の世界市場における主要ベンダーの市場シェアは？

7.医薬品有効成分の世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • バイオ医薬品の普及に伴いジェネリック医薬品の重要性が高まる
    • 医薬品有効成分の技術の進歩
    • 創薬と開発におけるAIベースのツールと臓器オンチップモデルの採用
  • 抑制要因
    • 各国における医薬品の非支持的な価格統制政策
    • 偽造医薬品の入手可能性の増加
  • 機会
    • バイオシミラーの出現
    • 非常に効果的な医薬品有効成分
  • 課題
    • 製造プロセスに伴う高コスト
    • 製品の差別化に関する懸念
• 市場動向
• COVID-19の累積的な影響
• ロシア・ウクライナ紛争の累積的影響
• 高インフレの累積的影響
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 規制の枠組み
• 顧客のカスタマイズ
  • 市場エコシステム

第6章 医薬品有効成分市場：タイプ別

• イントロダクション
• 一般医薬品有効成分
• 革新的医薬品有効成分

第7章 医薬品有効成分市場：合成別

• イントロダクション
• バイオテクノロジー
• 合成

第8章 医薬品有効成分市場：メーカー別

• イントロダクション
• キャプティブ
• マーチャント

第9章 医薬品有効成分市場：治療用途別

• イントロダクション
• 心血管疾患
• 伝染病
• 糖尿病
• 腫瘍学
• 疼痛管理
• 呼吸器疾患

第10章 南北アメリカの医薬品有効成分市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の医薬品有効成分市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの医薬品有効成分市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• FPNVポジショニングマトリクス
• 市場シェア分析：主要企業別
• 競合シナリオ分析：主要企業別

第14章 掲載企業一覧

第15章 付録

• ディスカッションガイド
• ライセンスと価格について

LIST OF FIGURES

• FIGURE 1. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET RESEARCH PROCESS
• FIGURE 2. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2022 VS 2030
• FIGURE 3. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
• FIGURE 5. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2022 VS 2030 (%)
• FIGURE 6. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MANUFACTURER, 2022 VS 2030 (%)
• FIGURE 7. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2022 VS 2030 (%)
• FIGURE 8. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 9. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET DYNAMICS
• FIGURE 10. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MANUFACTURER, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 15. UNITED STATES ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 18. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 19. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 5. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY GENERIC ACTIVE PHARMACEUTICAL INGREDIENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INNOVATIVE ACTIVE PHARMACEUTICAL INGREDIENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 8. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MANUFACTURER, 2018-2030 (USD MILLION)
• TABLE 11. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY CAPTIVE API MANUFACTURERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MERCHANT API MANUFACTURERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 14. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COMMUNICABLE DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY RESPIRATORY DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MANUFACTURER, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 26. ARGENTINA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MANUFACTURER, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 29. BRAZIL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 30. BRAZIL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 31. BRAZIL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MANUFACTURER, 2018-2030 (USD MILLION)
• TABLE 32. BRAZIL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 33. CANADA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 34. CANADA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 35. CANADA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MANUFACTURER, 2018-2030 (USD MILLION)
• TABLE 36. CANADA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 37. MEXICO ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 38. MEXICO ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 39. MEXICO ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MANUFACTURER, 2018-2030 (USD MILLION)
• TABLE 40. MEXICO ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 41. UNITED STATES ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 42. UNITED STATES ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 43. UNITED STATES ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 44. UNITED STATES ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MANUFACTURER, 2018-2030 (USD MILLION)
• TABLE 45. UNITED STATES ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 46. ASIA-PACIFIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 47. ASIA-PACIFIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 48. ASIA-PACIFIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 49. ASIA-PACIFIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MANUFACTURER, 2018-2030 (USD MILLION)
• TABLE 50. ASIA-PACIFIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 51. AUSTRALIA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 52. AUSTRALIA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 53. AUSTRALIA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MANUFACTURER, 2018-2030 (USD MILLION)
• TABLE 54. AUSTRALIA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 55. CHINA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 56. CHINA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 57. CHINA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MANUFACTURER, 2018-2030 (USD MILLION)
• TABLE 58. CHINA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 59. INDIA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 60. INDIA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 61. INDIA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MANUFACTURER, 2018-2030 (USD MILLION)
• TABLE 62. INDIA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 63. INDONESIA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 64. INDONESIA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 65. INDONESIA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MANUFACTURER, 2018-2030 (USD MILLION)
• TABLE 66. INDONESIA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 67. JAPAN ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 68. JAPAN ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 69. JAPAN ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MANUFACTURER, 2018-2030 (USD MILLION)
• TABLE 70. JAPAN ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 71. MALAYSIA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 72. MALAYSIA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 73. MALAYSIA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MANUFACTURER, 2018-2030 (USD MILLION)
• TABLE 74. MALAYSIA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 75. PHILIPPINES ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 76. PHILIPPINES ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 77. PHILIPPINES ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MANUFACTURER, 2018-2030 (USD MILLION)
• TABLE 78. PHILIPPINES ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 79. SINGAPORE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 80. SINGAPORE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 81. SINGAPORE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MANUFACTURER, 2018-2030 (USD MILLION)
• TABLE 82. SINGAPORE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 83. SOUTH KOREA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 84. SOUTH KOREA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 85. SOUTH KOREA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MANUFACTURER, 2018-2030 (USD MILLION)
• TABLE 86. SOUTH KOREA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 87. TAIWAN ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 88. TAIWAN ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 89. TAIWAN ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MANUFACTURER, 2018-2030 (USD MILLION)
• TABLE 90. TAIWAN ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. THAILAND ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 92. THAILAND ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 93. THAILAND ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MANUFACTURER, 2018-2030 (USD MILLION)
• TABLE 94. THAILAND ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 95. VIETNAM ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 96. VIETNAM ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 97. VIETNAM ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MANUFACTURER, 2018-2030 (USD MILLION)
• TABLE 98. VIETNAM ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. EUROPE, MIDDLE EAST & AFRICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 100. EUROPE, MIDDLE EAST & AFRICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 101. EUROPE, MIDDLE EAST & AFRICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 102. EUROPE, MIDDLE EAST & AFRICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MANUFACTURER, 2018-2030 (USD MILLION)
• TABLE 103. EUROPE, MIDDLE EAST & AFRICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 104. DENMARK ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 105. DENMARK ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 106. DENMARK ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MANUFACTURER, 2018-2030 (USD MILLION)
• TABLE 107. DENMARK ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 108. EGYPT ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 109. EGYPT ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 110. EGYPT ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MANUFACTURER, 2018-2030 (USD MILLION)
• TABLE 111. EGYPT ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 112. FINLAND ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 113. FINLAND ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 114. FINLAND ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MANUFACTURER, 2018-2030 (USD MILLION)
• TABLE 115. FINLAND ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 116. FRANCE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 117. FRANCE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 118. FRANCE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MANUFACTURER, 2018-2030 (USD MILLION)
• TABLE 119. FRANCE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 120. GERMANY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 121. GERMANY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 122. GERMANY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MANUFACTURER, 2018-2030 (USD MILLION)
• TABLE 123. GERMANY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 124. ISRAEL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 125. ISRAEL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 126. ISRAEL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MANUFACTURER, 2018-2030 (USD MILLION)
• TABLE 127. ISRAEL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 128. ITALY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 129. ITALY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 130. ITALY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MANUFACTURER, 2018-2030 (USD MILLION)
• TABLE 131. ITALY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 132. NETHERLANDS ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 133. NETHERLANDS ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 134. NETHERLANDS ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MANUFACTURER, 2018-2030 (USD MILLION)
• TABLE 135. NETHERLANDS ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 136. NIGERIA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 137. NIGERIA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 138. NIGERIA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MANUFACTURER, 2018-2030 (USD MILLION)
• TABLE 139. NIGERIA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 140. NORWAY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 141. NORWAY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 142. NORWAY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MANUFACTURER, 2018-2030 (USD MILLION)
• TABLE 143. NORWAY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 144. POLAND ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 145. POLAND ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 146. POLAND ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MANUFACTURER, 2018-2030 (USD MILLION)
• TABLE 147. POLAND ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 148. QATAR ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 149. QATAR ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 150. QATAR ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MANUFACTURER, 2018-2030 (USD MILLION)
• TABLE 151. QATAR ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 152. RUSSIA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 153. RUSSIA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 154. RUSSIA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MANUFACTURER, 2018-2030 (USD MILLION)
• TABLE 155. RUSSIA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 156. SAUDI ARABIA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 157. SAUDI ARABIA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 158. SAUDI ARABIA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MANUFACTURER, 2018-2030 (USD MILLION)
• TABLE 159. SAUDI ARABIA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 160. SOUTH AFRICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 161. SOUTH AFRICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 162. SOUTH AFRICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MANUFACTURER, 2018-2030 (USD MILLION)
• TABLE 163. SOUTH AFRICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 164. SPAIN ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 165. SPAIN ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 166. SPAIN ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MANUFACTURER, 2018-2030 (USD MILLION)
• TABLE 167. SPAIN ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 168. SWEDEN ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 169. SWEDEN ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 170. SWEDEN ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MANUFACTURER, 2018-2030 (USD MILLION)
• TABLE 171. SWEDEN ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 172. SWITZERLAND ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 173. SWITZERLAND ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 174. SWITZERLAND ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MANUFACTURER, 2018-2030 (USD MILLION)
• TABLE 175. SWITZERLAND ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 176. TURKEY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 177. TURKEY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 178. TURKEY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MANUFACTURER, 2018-2030 (USD MILLION)
• TABLE 179. TURKEY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 180. UNITED ARAB EMIRATES ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 181. UNITED ARAB EMIRATES ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 182. UNITED ARAB EMIRATES ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MANUFACTURER, 2018-2030 (USD MILLION)
• TABLE 183. UNITED ARAB EMIRATES ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 184. UNITED KINGDOM ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 185. UNITED KINGDOM ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 186. UNITED KINGDOM ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MANUFACTURER, 2018-2030 (USD MILLION)
• TABLE 187. UNITED KINGDOM ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 188. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 189. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 190. ACTIVE PHARMACEUTICAL INGREDIENTS MARKET LICENSE & PRICING

The Global Active Pharmaceutical Ingredients Market is forecasted to grow significantly, with a projected USD 227.01 billion in 2023 at a CAGR of 6.67% and expected to reach a staggering USD 357.27 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Active Pharmaceutical Ingredients Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Active Pharmaceutical Ingredients Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Type, market is studied across Generic Active Pharmaceutical Ingredients and Innovative Active Pharmaceutical Ingredients. The Generic Active Pharmaceutical Ingredients is projected to witness significant market share during forecast period.

Based on Synthesis, market is studied across Biotech Active Pharmaceutical Ingredients and Synthetic Active Pharmaceutical Ingredients. The Biotech Active Pharmaceutical Ingredients is projected to witness significant market share during forecast period.

Based on Manufacturer, market is studied across Captive API Manufacturers and Merchant API Manufacturers. The Merchant API Manufacturers is projected to witness significant market share during forecast period.

Based on Therapeutic Application, market is studied across Cardiovascular Diseases, Communicable Diseases, Diabetes, Oncology, Pain Management, and Respiratory Diseases. The Oncology is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Active Pharmaceutical Ingredients Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Active Pharmaceutical Ingredients Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Active Pharmaceutical Ingredients Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Active Pharmaceutical Ingredients Market?

4. What is the competitive strategic window for opportunities in the Global Active Pharmaceutical Ingredients Market?

5. What are the technology trends and regulatory frameworks in the Global Active Pharmaceutical Ingredients Market?

6. What is the market share of the leading vendors in the Global Active Pharmaceutical Ingredients Market?

7. What modes and strategic moves are considered suitable for entering the Global Active Pharmaceutical Ingredients Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Active Pharmaceutical Ingredients Market, by Type, 2022 vs 2030
• 4.3. Active Pharmaceutical Ingredients Market, by Synthesis, 2022 vs 2030
• 4.4. Active Pharmaceutical Ingredients Market, by Manufacturer, 2022 vs 2030
• 4.5. Active Pharmaceutical Ingredients Market, by Therapeutic Application, 2022 vs 2030
• 4.6. Active Pharmaceutical Ingredients Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing importance of generics coupled with uptakes of biopharmaceuticals
    • 5.1.1.2. Technological advancements in active pharmaceutical ingredients
    • 5.1.1.3. Adoption of AI-based tools and organ-on-chip models in drug discovery & development
  • 5.1.2. Restraints
    • 5.1.2.1. Unsupportive price control policies for drug across various countries
    • 5.1.2.2. Increasing availability of counterfeit drugs
  • 5.1.3. Opportunities
    • 5.1.3.1. Emergence of biosimilars
    • 5.1.3.2. Highly effective active pharmaceutical ingredients
  • 5.1.4. Challenges
    • 5.1.4.1. High cost associated with the manufacturing process
    • 5.1.4.2. Concern associated with the product differentiation
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization
  • 5.9.1. Market Ecosystem

6. Active Pharmaceutical Ingredients Market, by Type

• 6.1. Introduction
• 6.2. Generic Active Pharmaceutical Ingredients
• 6.3. Innovative Active Pharmaceutical Ingredients

7. Active Pharmaceutical Ingredients Market, by Synthesis

• 7.1. Introduction
• 7.2. Biotech Active Pharmaceutical Ingredients
• 7.3. Synthetic Active Pharmaceutical Ingredients

8. Active Pharmaceutical Ingredients Market, by Manufacturer

• 8.1. Introduction
• 8.2. Captive API Manufacturers
• 8.3. Merchant API Manufacturers

9. Active Pharmaceutical Ingredients Market, by Therapeutic Application

• 9.1. Introduction
• 9.2. Cardiovascular Diseases
• 9.3. Communicable Diseases
• 9.4. Diabetes
• 9.5. Oncology
• 9.6. Pain Management
• 9.7. Respiratory Diseases

10. Americas Active Pharmaceutical Ingredients Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Active Pharmaceutical Ingredients Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Active Pharmaceutical Ingredients Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. FPNV Positioning Matrix
• 13.2. Market Share Analysis, By Key Player
• 13.3. Competitive Scenario Analysis, By Key Player

14. List of Company Mentioned

15. Appendix

• 15.1. Discussion Guide
• 15.2. License & Pricing